Project Grant K01DA063744
Award Date 8/1/26
Completion Date 7/31/31
Dollars Obligated $403K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
- The National Institute on Drug Abuse awarded the University of California, San Diego $1,468,376 under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2026, to conduct a prospective study characterizing sex-specific cannabinoid and endocannabinoid biomarkers as predictors of neuropsychological, behavioral, and withdrawal outcomes during cannabis abstinence in emerging adults. The research will recruit 220 participants aged 18–25 (balanced by sex, 64 percent with heavy...
- The National Institute on Drug Abuse awarded the University of California, San Diego $1,233,586 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate epigenetic and neuroimmune mechanisms underlying cannabis-cannabinoid neuroimmunomodulation in people living with HIV. The recipient will conduct integrated clinical, postmortem, and mechanistic research examining how THC and CBD reshape the neuroimmune axis in people living with HIV through...
- The National Institute on Drug Abuse awarded the University of California, San Diego $3,001,884 under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 1, 2026, to conduct translational and cross-species studies of cannabis use and HIV effects on mitochondrial homeostasis in brain macrophages. The research combines a clinical observational study with cellular and in vivo preclinical models to determine how cannabis use affects TREM2-mediated changes in mitochondrial function...
- The National Institute on Drug Abuse awarded $121,500 to the University of Kansas Center For Research Inc. on December 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). The research investigates contextual factors influencing cannabis use and behavioral economic demand in naturalistic environments. The project employs ecological momentary assessment and behavioral economic purchase tasks to extend laboratory-based research into real-world settings. The study will conduct...
- The National Institute on Drug Abuse awarded the University of California, San Diego $142,161 on August 19, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research examining the impact of cannabis use on visual functioning and visuospatial neuropsychological performance in cannabis users with and without HIV. The research will examine performance on visuospatial neuropsychological assessments predicted to indicate driving safety in cannabis users stratified...
- The National Institute on Drug Abuse awarded the University of California, San Diego $879,000 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate a novel episode-based paradigm for studying how family processes drive adolescent substance use. The project will collect real-time, real-world intensive longitudinal data on discrete parent and youth behaviors before and after episodes of substance use from 90 adolescents who use substances....
- The National Institute on Drug Abuse, part of the Department of Health and Human Services National Institutes of Health, awarded the University of California, San Diego $192,930 in project grant funding on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports mentoring in patient-oriented research on central nervous system dysfunction in individuals with HIV and substance use. The funded activities provide protected time for the principal...
- The National Institute on Drug Abuse awarded The Regents of the University of California, San Francisco $246,000 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the concurrent use of cannabis and stimulant medications on cardiovascular disease risk. The research will evaluate whether cannabis smoking and prescribed stimulant medication used together exert additive or synergistic effects on cardiovascular function and circulating biomarkers of...
- The National Institute on Drug Abuse awarded the Research Foundation For Mental Hygiene, Inc. (operating through its New York State Psychiatric Institute division) $195,804 on August 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a five-year research project examining how cannabis influences nicotine use among young and emerging adults (ages 18–35) who use electronic nicotine delivery systems. The study integrates human laboratory methods with...
- The National Institute on Drug Abuse awarded Public Health Institute $1,084,374 on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a prospective cohort study examining cannabis use among sober living house residents and its relationship to substance use, mental health, and recovery outcomes. The study will recruit 400 residents from 35 sober living houses, stratified into groups with recent cannabis use (past 30 days) and non-recent use, and follow them...